SLC8B1
Basic information
Region (hg38): 12:113298759-113359493
Previous symbols: [ "SLC24A6" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC8B1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 56 | 57 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 56 | 1 | 0 |
Variants in SLC8B1
This is a list of pathogenic ClinVar variants found in the SLC8B1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-113299824-C-T | not specified | Uncertain significance (Oct 24, 2024) | ||
12-113299829-A-G | not specified | Uncertain significance (Nov 10, 2024) | ||
12-113299869-C-T | not specified | Uncertain significance (May 20, 2024) | ||
12-113299892-A-C | not specified | Uncertain significance (Aug 20, 2024) | ||
12-113299935-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
12-113299940-G-C | not specified | Uncertain significance (May 30, 2024) | ||
12-113299962-C-T | not specified | Uncertain significance (Nov 01, 2022) | ||
12-113304340-C-G | not specified | Uncertain significance (Aug 26, 2022) | ||
12-113304340-C-T | not specified | Uncertain significance (Sep 12, 2023) | ||
12-113304365-G-C | not specified | Uncertain significance (Feb 15, 2023) | ||
12-113304377-C-A | not specified | Uncertain significance (Feb 15, 2025) | ||
12-113304377-C-G | not specified | Uncertain significance (Oct 05, 2022) | ||
12-113304377-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
12-113306533-C-T | not specified | Uncertain significance (Oct 14, 2023) | ||
12-113306548-C-T | not specified | Uncertain significance (Feb 13, 2025) | ||
12-113306559-G-C | not specified | Uncertain significance (Jun 25, 2024) | ||
12-113307747-C-G | not specified | Uncertain significance (Apr 11, 2023) | ||
12-113307793-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
12-113307799-C-T | not specified | Uncertain significance (Feb 22, 2025) | ||
12-113307817-T-C | not specified | Uncertain significance (Nov 21, 2024) | ||
12-113310248-G-A | not specified | Uncertain significance (Jan 01, 2025) | ||
12-113310257-T-G | not specified | Uncertain significance (Feb 08, 2025) | ||
12-113310263-A-G | not specified | Uncertain significance (Jul 10, 2024) | ||
12-113310290-A-T | not specified | Uncertain significance (Dec 11, 2024) | ||
12-113310314-C-T | not specified | Uncertain significance (Sep 06, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC8B1 | protein_coding | protein_coding | ENST00000552014 | 15 | 60735 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.03e-16 | 0.0280 | 125500 | 1 | 247 | 125748 | 0.000987 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.318 | 326 | 343 | 0.952 | 0.0000208 | 3717 |
Missense in Polyphen | 102 | 114.34 | 0.89209 | 1280 | ||
Synonymous | -0.0153 | 152 | 152 | 1.00 | 0.00000940 | 1283 |
Loss of Function | 0.539 | 26 | 29.1 | 0.892 | 0.00000152 | 300 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000402 | 0.000387 |
Ashkenazi Jewish | 0.00828 | 0.00817 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.000186 | 0.000185 |
European (Non-Finnish) | 0.000593 | 0.000589 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.00232 | 0.00232 |
Other | 0.00164 | 0.00163 |
dbNSFP
Source:
- Function
- FUNCTION: Mitochondrial sodium/calcium antiporter that mediates sodium-dependent calcium efflux from mitochondrion, by mediating the exchange of 3 sodium ions per 1 calcium ion (PubMed:20018762, PubMed:22829870, PubMed:23056385, PubMed:24898248, PubMed:28219928). Plays a central role in mitochondrial calcium homeostasis by mediating mitochondrial calcium extrusion: calcium efflux is essential for mitochondrial function and cell survival, notably in cardiomyocytes (By similarity). Regulates rates of glucose-dependent insulin secretion in pancreatic beta-cells during the first phase of insulin secretion: acts by mediating efflux of calcium from mitochondrion, thereby affecting cytoplasmic calcium responses (PubMed:23056385). Required for store-operated Ca(2+) entry (SOCE) and Ca(2+) release-activated Ca(2+) (CRAC) channel regulation: sodium transport by SLC8B1 leads to promote calcium-shuttling that modulates mitochondrial redox status, thereby regulating SOCE activity (PubMed:28219928). Involved in B-lymphocyte chemotaxis (By similarity). Able to transport Ca(2+) in exchange of either Li(+) or Na(+), explaining how Li(+) catalyzes Ca(2+) exchange (PubMed:15060069). In contrast to other members of the family its function is independent of K(+) (PubMed:15060069). {ECO:0000250|UniProtKB:Q925Q3, ECO:0000269|PubMed:15060069, ECO:0000269|PubMed:20018762, ECO:0000269|PubMed:22829870, ECO:0000269|PubMed:23056385, ECO:0000269|PubMed:24898248, ECO:0000269|PubMed:28219928}.;
- Pathway
- Sodium/Calcium exchangers;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Mitochondrial calcium ion transport
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -1
- rvis_percentile_EVS
- 8.54
Haploinsufficiency Scores
- pHI
- 0.365
- hipred
- N
- hipred_score
- 0.251
- ghis
- 0.503
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc8b1
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- ion transport;mitochondrial calcium ion transmembrane transport;sodium ion transmembrane transport;glucose homeostasis;regulation of insulin secretion;response to stimulus;regulation of cytosolic calcium ion concentration;mitochondrial calcium ion homeostasis;regulation of cardiac muscle cell membrane potential;calcium export from the mitochondrion;regulation of lymphocyte chemotaxis;regulation of store-operated calcium entry
- Cellular component
- mitochondrial inner membrane;plasma membrane;mitochondrial crista;integral component of mitochondrial membrane;sarcolemma
- Molecular function
- calcium:sodium antiporter activity;calcium:cation antiporter activity;protein homodimerization activity;calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential